02 Feb Press Release Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock February 2, 2023 Posted by Ulisses Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a supplement to its previously issued “Frequently Asked Questions” document under the Read more
23 Jan SEC FIlings General statement of acquisition of beneficial ownership January 23, 2023 Posted by Ulisses Read more